FDA-Inspected Site

Abbott Diabetes Care, Inc.

21 FDA inspections are on record for Abbott Diabetes Care, Inc. in Alameda, United States.

483· Form 483 issued

Alameda, United States · Last updated August 15, 2026

Overview

  • 21 FDA inspections are on record.
  • 7 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-10-23.

At a glance

Inspections

21

Form 483s

7

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
14 Oct 2025 – 23 Oct 2025Medical Devices & Rad HealthWLView 483 →
6 Nov 2023 – 16 Nov 2023Medical Devices & Rad HealthClean
11 Apr 2022 – 21 Apr 2022Medical Devices & Rad Health483View 483 →
21 Apr 2021 – 29 Apr 2021Medical Devices & Rad HealthClean
16 Jul 2018 – 19 Jul 2018Medical Devices & Rad HealthClean
28 Nov 2017 – 4 Dec 2017Medical Devices & Rad Health483View 483 →
10 Oct 2017 – 13 Oct 2017Medical Devices & Rad HealthClean
18 Oct 2016 – 21 Oct 2016Medical Devices & Rad HealthClean
7 Mar 2016 – 10 Mar 2016Medical Devices & Rad HealthClean
7 Oct 2015 – 22 Oct 2015Medical Devices & Rad Health483View 483 →
6 Jan 2014 – 7 Feb 2014Medical Devices & Rad HealthClean
9 May 2013 – 31 May 2013Medical Devices & Rad Health483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

23 Oct 2025
21 CFR 803.50(a)(2)

Individual Report of Malfunction

Cited by Suyang Qin, Marlo-Ian M Alintanahin

23 Oct 2025
21 CFR 820.30(h)

Design transfer - Lack of or inadequate procedures

Cited by Suyang Qin, Marlo-Ian M Alintanahin

21 Apr 2022
21 CFR 820.198(c)

Investigation of device failures

Cited by Maida Henesian, Katlin N Stubbs

4 Dec 2017
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by Quynh Strandberg

4 Dec 2017
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by Quynh Strandberg

Investigators

FDA investigators tied to this site in the record.

MDSAP WilliamsA2 insp.
Suyang Qin1 insp.
Elizabeth A Dakan1 insp.
Alla Dubrovsky1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.198(a)Cited across public-safe Form 483 observations6x
21 CFR 803.50(a)(2)Cited across public-safe Form 483 observations3x
21 CFR 820.100(a)Cited across public-safe Form 483 observations2x
21 CFR 820.198(c)Cited across public-safe Form 483 observations2x
21 CFR 820.25(a)Cited across public-safe Form 483 observations2x
21 CFR 820.25(b)Cited across public-safe Form 483 observations2x
21 CFR 820.90(a)Cited across public-safe Form 483 observations2x
21 CFR 820.198(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.20(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.30(h)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x
21 CFR 820.80(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Abbott Diabetes Care, Inc.'s 7 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat